Each week we highlight five things affecting the life sciences industry. Here's the latest. Navigating the future of biopharma collaborations amid U.S.-China tensions Per BioSpace, political and legislative changes are creating uncertainty for Chinese and U.S. biopharma collaborations, particularly ... READ MORE >
Health care
5 things to know in life sciences: Week of March 25, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. FDA issues warnings on plastic syringes from China According to MedTech Dive, the U.S. Food and Drug Administration has issued three warning letters as part of its investigation into plastic syringes made in ... READ MORE >
Health care’s challenge: Navigating the impact of a cyberattack rocking the industry
Some providers and physician groups are facing an existential cash flow crisis as the problems pile up due to the recent cyberattack on Change Healthcare, one of the world’s largest health care clearinghouses for medical claims transactions. Outcomes of this event could disrupt health care transactions ... READ MORE >
5 things to know in life sciences: Week of March 18, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Revolutionizing surgery: Nvidia and Johnson & Johnson's AI collaboration Per CNBC, Nvidia and Johnson & Johnson are collaborating to develop new artificial intelligence applications for surgery, ... READ MORE >
5 things to know in life sciences: Week of March 11, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Public biotech financings on pace for best quarter since 2021 According to Biopharma Dive, publicly traded biotech companies have raised nearly $10 billion in follow-on stock offerings during the first ... READ MORE >
5 things to know in life sciences: Week of March 4, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Biden administration receives counteroffers from drug companies The Biden administration has received counteroffers from drug manufacturers in Medicare price negotiations under the Inflation Reduction Act, ... READ MORE >
5 things to know in life sciences: Week of Feb. 26, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. 3D bioprinting: New era in regenerative medicine Recent advancements in 3D bioprinting, including the development of functional human brain tissue and replacement tissue for treating injured cartilage, signal ... READ MORE >
5 things to know in life sciences: Week of Feb. 19, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA warns against fraudulent data in medical device premarket submissions The U.S. Food and Drug Administration is alerting medical device manufacturers about the rise in fraudulent and unreliable laboratory ... READ MORE >
5 things to know in life sciences: Week of Feb. 12, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Global health care’s push for climate resilience Following NHS England's 2020 commitment to net zero emissions by 2045, over 20 countries are adopting similar goals, aiming to create climate-resilient health ... READ MORE >
5 things to know in life sciences: Week of Feb. 5, 2024
This week we highlight the acquisition of a contract manufacturing organization to meet the high demand for GLP-1s, the funding of Australian medtech startups, and a shift in pharma from large deals to smaller acquisitions. We also examine the investment into the psychedelic medicine industry. ... READ MORE >